H.R. 1563

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1563 Introduced in House (IH)]

<DOC>

119th CONGRESS
1st Session
H. R. 1563

To amend the Controlled Substances Act to clarify that the possession, 
sale, purchase, importation, exportation, or transportation of drug 
testing equipment that tests for the presence of fentanyl or xylazine 
is not unlawful.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

February 25, 2025

Ms. Crockett (for herself and Mr. Gooden) introduced the following 
bill; which was referred to the Committee on the Judiciary, and in 
addition to the Committee on Energy and Commerce, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
of such provisions as fall within the jurisdiction of the committee 
concerned

_______________________________________________________________________

A BILL

To amend the Controlled Substances Act to clarify that the possession, 
sale, purchase, importation, exportation, or transportation of drug 
testing equipment that tests for the presence of fentanyl or xylazine 
is not unlawful.

Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Safeguarding Testing and Overdose 
Prevention Against Fentanyl and Xylazine Act'' or the ``STOP Fentanyl 
and Xylazine Act''.

SEC. 2. CLARIFICATION REGARDING THE TREATMENT OF EQUIPMENT THAT 
INDICATES THE PRESENCE OF FENTANYL OR XYLAZINE IN A 
COMPOUND.

Section 422 of the Controlled Substances Act (21 U.S.C. 863) is 
amended by adding at the end the following:
``(g) Clarification.--This section does not apply to the 
possession, sale, purchase, importation, exportation, or transportation 
of equipment for which the intended use is to indicate the presence of 
fentanyl or xylazine in a compound.''.
<all>